Epigenetic modifications occur in response to environmental changes and play a fundamental role in gene expression following environmental stimuli. Major epigenetic events include methylation and acetylation of histones and regulatory factors, DNA methylation, and small non-coding RNAs. Diet, pollution, infections, and other environmental factors have profound effects on epigenetic modifications and trigger susceptibility to diseases. Despite a growing body of literature addressing the role of the environment on gene expression, very little is known about the epigenetic pathways involved in the modulation of inflammatory and anti-inflammatory genes. This review summarizes the current knowledge about epigenetic control mechanisms during the inflammatory response.
AdcockIMTsaprouniLBhavsarPItoK (2007). Epigenetic regulation of airway inflammation. Curr Opin Immunol19:694-700.
2.
AgrawalATayJYangGEAgrawalSGuptaS (2010). Age-associated epigenetic modifications in human DNA increase its immunogenicity. Aging2:93-100.
3.
AnestVHansonJLCogswellPCSteinbrecherKAStrahlBDBaldwinAS (2003). A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature423:659-663.
4.
BarnesPJ (2009). Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc6:693-696.
5.
BarrosSPOffenbacherS (2009). Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res88:400-408.
6.
BarskiACuddapahSCuiKRohTYSchonesDEWangZ. (2007). High-resolution profiling of histone methylations in the human genome. Cell129:823-387.
7.
BenakanakereMRLiQEskanMASinghAVZhaoJGaliciaJC. (2009). Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem284:23107-23115.
8.
BernsteinBEMikkelsenTSXieXKamalMHuebertDJCuffJ. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell125:315-326.
9.
BobetsisYABarrosSPOffenbacherS (2006). Exploring the relationship between periodontal disease and pregnancy complications. J Am Dent Assoc137(Suppl):7S-13S.
10.
BobetsisYABarrosSPLinDMWeidmanJRDolinoyDCJirtleRL. (2007). Bacterial infection promotes DNA hypermethylation. J Dent Res86:169-174.
11.
BobetsisYABarrosSPLinDMArceRMOffenbacherS (2010). Altered gene expression in murine placentas in an infection-induced intrauterine growth restriction model: a microarray analysis. J Reprod Immunol85:140-148.
12.
BowmanRVWrightCMDavidsonMRFrancisSMYangIAFongKM (2009). Epigenomic targets for the treatment of respiratory disease. Expert Opin Ther Targets13:625-640.
13.
BrooksWHLe DantecCPersJOYouinouPRenaudineauY (2010). Epigenetics and autoimmunity. J Autoimmun34:J207-J219.
14.
CamposEIReinbergD (2009). Histones: annotating chromatin. Annu Rev Genet43:559-599.
15.
ChenXEl GazzarMYozaBKMcCallCE (2009). The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem284:27857-27865.
16.
ChengXBlumenthalRM (2010). Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry49:2999-3008.
17.
CheungHHLeeTLRennertOMChanWY (2009). DNA methylation of cancer genome. Birth Defects Res C Embryo Today87:335-350.
18.
De SantaFTotaroMGProsperiniENotarbartoloSTestaGNatoliG (2007). The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell130:1083-1094.
19.
De SantaFNarangVYapZHTusiBKBurgoldTAustenaaL. (2009). Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J28:3341-3352.
20.
DingSZGoldbergJBHatakeyamaM (2010). Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol6:851-862.
El GazzarMAMcCallCE (2010). MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem[Epub ahead of print, April 30, 2010] (in press).
23.
El GazzarMMcCallCE (2010). MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem285:20940-20951.
24.
El GazzarMYozaBKChenXHuJHawkinsGAMcCallCE (2008). G9a and HP1 couple histone and DNA methylation to TNFα transcription silencing during endotoxin tolerance. J Biol Chem283:32198-32208.
25.
El MezayenREl GazzarMMyerRHighKP (2009). Aging-dependent upregulation of IL-23p19 gene expression in dendritic cells is associated with differential transcription factor binding and histone modifications. Aging Cell8:553-565.
26.
FabbriMGarzonRCimminoALiuZZanesiNCallegariE. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA104:15805-15810.
27.
FeinbergAP (2007). Phenotypic plasticity and the epigenetics of human disease. Nature447:433-440.
28.
FriedmanJMJonesPALiangG (2009). The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer. Cell Cycle8:2313-2314.
GhoshSKarinM (2009). Missing pieces in the NF-kappaB puzzle. Cell109(Suppl):81S-96S.
31.
GomezRSDutraWOMoreiraPR (2009). Epigenetics and periodontal disease: future perspectives. Inflamm Res58:625-629.
32.
HahnMAHahnTLeeDHEsworthyRSKimBWRiggsAD. (2008). Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res68:10280-10289.
33.
HeintzmanNDStuartRKHonGFuYChingCWHawkinsRD. (2007). Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet39:311-318.
34.
HermanJGBaylinSB (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med349:2042-2054.
35.
HermannAGowherHJeltschA (2004). Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci61:2571-2587.
36.
HuJLZhouBOZhangRRZhangKLZhouJQXuGL (2009). The N-terminus of histone H3 is required for de novo DNA methylation in chromatin. Proc Natl Acad Sci USA106:22187-22192.
37.
JuanAHKumarRMMarxJGYoungRASartorelliV (2009). Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell36:61-74.
38.
IliopoulosDHirschHAStruhlK (2009). An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell139:693-706.
IshiiMWenHCorsaCALiuTCoelhoALAllenRM. (2009). Epigenetic regulation of the alternatively activated macrophage phenotype. Blood114:3244-3254.
41.
JeltschA (2006). Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol301:203-225.
42.
JonesPALiangG (2009). Rethinking how DNA methylation patterns are maintained. Nat Rev Genet10:805-811.
43.
KarbergS (2009). Switching on epigenetic therapy. Cell139:1029-1031.
44.
KarouzakisEGayREGaySNeidhartM (2009). Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol5:266-272.
45.
KatayamaYTakahashiMKuwayamaH (2009). Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem Biophys Res Commun388:496-500.
46.
KerppolaTK (2009). Polycomb group complexes—many combinations, many functions. Trends Cell Biol19:692-704.
47.
KhalilAMGuttmanMHuarteMGarberMRajARivea MoralesD. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA106:11667-11672.
48.
KhansariNShakibaYMahmoudiM (2009). Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov3:73-80.
49.
LalGZhangNvan der TouwWDingYJuWBottingerEP. (2009). Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol182:259-273.
50.
LanFShiY (2009). Epigenetic regulation: methylation of histone and non-histone proteins. Sci China C Life Sci52:311-322.
51.
LandeiraDSauerSPootRDvorkinaMMazzarellaLJørgensenHF. (2010). Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA polymerase II to developmental regulators. Nat Cell Biol12:618-624.
LewisBPBurgeCBBartelDP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell120:15-20.
54.
LiGMargueronRKuMChambonPBernsteinBEReinbergD (2010). Jarid2 and PRC2, partners in regulating gene expression. Genes Dev15:368-380.
55.
LiHXieHLiuWHuRHuangBTanYF. (2009). A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest119:3666-3677.
56.
LiZHassanMQJafferjiMAqeilanRIGarzonRCroceCM. (2009). Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem284:15676-15684.
57.
LiuGFriggeriAYangYParkYJTsurutaYAbrahamE (2009). miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA106:15819-15824.
58.
LuFStedmanWYousefMRenneRLiebermanPM (2010). Epigenetic regulation of KSHV latency by viral-encoded microRNAs that target Rta and the cellular Rb12-DNMT pathway. J Virol84:2697-2706.
59.
Maciejewska RodriguesHJüngelAGayREGayS (2009). Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Mol Immunol47:12-18.
60.
MannJChuDCMaxwellAOakleyFZhuNLTsukamotoH. (2009). MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology138:705-714.
61.
McCabeMTBrandesJCVertinoPM (2009). Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res15:3927-3937.
62.
MedzhitovR (2008). Origin and physiological roles of inflammation. Nature454:428-435.
63.
MedzhitovRHorngT (2009). Transcriptional control of the inflammatory response. Nat Rev Immunol9:692-703.
64.
MikkelsenTSKuMJaffeDBIssacBLiebermanEGiannoukosG. (2007). Genome-wide maps of chromatin state in pluripotent and differentiated cells. Nature448:553-560.
65.
MoreyLHelinK (2010). Polycomb group protein-mediated repression of transcription. Trends Biochem Sci35:323-332.
66.
NgEKTsangWPNgSSJinHCYuJLiJJ. (2009). MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer101:699-706.
67.
NiwaTTsukamotoTToyodaTMoriATanakaHMaekitaT. (2010). Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res70:1430-1440.
68.
NoonanEJPlaceRFPookotDBasakSWhitsonJMHirataH. (2009). miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene28:1714-1724.
69.
O’ConnellRMChaudhuriAARaoDSBaltimoreD (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA106:7113-7118.
70.
PageTHSmolinskaMGillespieJUrbaniakAMFoxwellBM (2009). Tyrosine kinases and inflammatory signalling. Curr Mol Med9:69-85.
71.
PasiniDCloosPAWalfridssonJOlssonLBukowskiJPJohansenJV. (2010). JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature464:306-310.
72.
PengJCValouevASwigutTZhangJZhaoYSidowA. (2009). Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell139:1290-1302.
73.
RajputSWilberA (2010). Roles of inflammation in cancer initiation, progression, and metastasis. Front Biosci2:176-183.
74.
RottachAFrauerCPichlerGBonapaceIMSpadaFLeonhardtH (2010). The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res38:1796-1804.
SanderSBullingerLKlapprothKFiedlerKKestlerHABarthTF. (2008). MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood112:4202-4212.
ShenXKimWFujiwaraYSimonMDLiuYMysliwiecMR. (2009). Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell139:1303-1314.
79.
ShutoTFurutaTObaMXuHLiJDCheungJ. (2006). Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J20:782-784.
80.
SimonJAKingstonRE (2009). Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol10:697-708.
81.
SonkolyEPivarcsiA (2009). microRNAs in inflammation. Int Rev Immunol28:535-561.
82.
StrietholtSMaurerBPetersMAPapTGayS (2008). Epigenetic modifications in rheumatoid arthritis. Arthritis Res Ther10:219.
TaganovKDBoldinMPChangKJBaltimoreD (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA103:12481-12486.
85.
TakahashiKSugiYHosonoAKaminogawaS (2009). Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J Immunol183:6522-6529.
86.
ThompsonRFEinsteinFH (2010). Epigenetic basis for fetal origins of age-related disease. J Women’s Health19:581-587.
87.
TimmermannSLehrmannHPolesskayaAHarel-BellanA (2001). Histone acetylation and disease. Cell Mol Life Sci58:728-736.
88.
TuddenhamLWheelerGNtounia-FousaraSWatersJHajihosseiniMKClarkI. (2006). The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett580:4214-4217.
89.
ValeriNVanniniIFaniniFCaloreFAdairBFabbriM (2009). Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome20:573-580.
90.
VaramballySCaoQManiRSShankarSWangXAteeqB. (2008). Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science322:1695-1699.
91.
VillagraASotomayorEMSetoE (2010). Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene29:157-173.
92.
ViselABlowMJLiZZhangTAkiyamaJAHoltA. (2009). ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature457:854-858.
93.
WeberMSchübelerD (2007). Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol19:273-280.
94.
WellsAD (2009). New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting. J Immunol182:7331-7341.
95.
WierdaRJGeutskensSBJukemaJWQuaxPHvan den ElsenPJ (2010). Epigenetics in atherosclerosis and inflammation. J Cell Mol Med[Epub ahead of print, January 30, 2010] (in press).
96.
WongCFTellamRL (2008). MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J Biol Chem283:9836-9843.
97.
WormJStenvangJPetriAFrederiksenKSObadSElménJ. (2009). Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp beta and down-regulation of G-CSF. Nucleic Acids Res37:5784-5792.
98.
XieXLuJKulbokasEJGolubTRMoothaVLindblad-TohK. (2005). Systematic discovery of regulatory motifs in human promoters and 3’ UTRs by comparison of several mammals. Nature434:338-345.
99.
YamamotoYVermaUNPrajapatiSKwakYTGaynorRB (2003). Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature423:655-659.
100.
YangJParkYZhangHXuXLaineGADellspergerKC. (2009). Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol296:H1850-H1858.
101.
YaoHRahmanI (2009). Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol9:375-383.
102.
ZhangSBarrosSPNiculescuMDMorettiAJPreisserJSOffenbacherS (2010). Alteration of PTGS2 promoter methylation in chronic periodontitis. J Dent Res89:133-137.
103.
ZhaoJSunBKErwinJASongJJLeeJT (2008). Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science322:750-756.
